FIELD: biotechnology, food industry.
SUBSTANCE: invention relates to biotechnology and food industry, namely to a biologically active additive (BAA) that allows to improve the functioning of the gastrointestinal tract, prevent dysbiosis and has a pronounced detoxifying, immunomodulating and regenerating properties. The BAA contain the following components, mg: cell-free bacterial filtrate dry “Metafiltrate BB-Bf” (based on Bifidobacterium bifidum) – 470, cell-free bacterial filtrate dry “Metafiltrate BB-Ln” (based on Bifidobacterium longum) – 430, cell-free bacterial filtrate dry “Metafiltrate BB-Ad” (based on Bifidobacterium adolescentis) – 410, cell-free bacterial filtrate dry “Metafiltrate BB-Br” (based on Bifidobacterium breve) – 400, cell-free bacterial filtrate dry “Metafiltrate LB-Hl” (based on Lactobacillus helveticus) – 252,506, cell-free bacterial filtrate dry “Metafiltrate Pr-Frd” (based on Propionibacterium freudenreichii) – 100, flora – 1375, lactulose 50% – 400, postbiotic metafiltrate “Subtisim” – 200, silicon dioxide – 30, endofulvin - 9.62, chitosan – 5, paraaminobenzoic acid – 2, nicotinamide – 1.81, calcium pantothenate – 0.654, riboflavin – 0.16, cysteine – 1.25, as well as excipients: pharmacopoeia glycerin – 1375 and lactic acid – 37.
EFFECT: invention makes it possible to obtain BAA for selective sorption of endotoxins and metabolic correction of intestinal microflora.
1 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
ORAL COMPOSITION CONTAINING NONPATHOGENIC MICROORGANISMS SHOWING ABILITY TO NORMALISE INTESTINAL MICROFLORA (VERSIONS) | 2008 |
|
RU2453320C2 |
ENTERAL DIABETIC MIXTURE CONTAINING METABIOTIC COMPLEX AND β-GLUCANS, FOR TREATMENT OF NUTRITIONAL DEFICIENCY IN CRITICALLY ILL PATIENTS | 2024 |
|
RU2832794C1 |
METHOD OF TREATING NUTRITIONAL DEFICIENCY IN PATIENTS WITH SEPSIS WITH ENTERAL MIXTURE CONTAINING METABIOTIC COMPLEX AND β-GLUCANS | 2024 |
|
RU2828960C1 |
IMMUNOBIOLOGICAL ANTIALLERGIC AGENT (VERSIONS) AND Lactobacillus acidophilus 100 "аш" PA STRAIN USED FOR PRODUCTION OF IMMUNOBIOLOGICAL ANTIALLERGIC AGENT | 2008 |
|
RU2431663C2 |
METHOD OF POSTBIOTIC PRODUCT PRODUCTION (OPTIONS) | 2017 |
|
RU2658777C1 |
BIFIDOBACTERIAL AND LACTOBACILLARY CONSORTIUM FOR PREPARING BACTERIAL PREPARATIONS AND DIETARY SUPPLEMENTS FOR CORRECTING GASTROINTESTINAL MICROFLORA IN CHILDREN AGED FROM THREE TO FOURTEEN, AND METHOD FOR PREPARING IT, DIETARY SUPPLEMENT AND BACTERIAL PREPARATION FOR TREATING DYSBIOTIC GASTROINTESTINAL CONDITIONS IN CHILDREN AGED FROM THREE TO FOURTEEN | 2012 |
|
RU2491335C1 |
METHOD OF TREATING NUTRITIONAL DEFICIENCY IN PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME OF MILD, MODERATE AND SEVERE ENTERAL MIXTURE CONTAINING METABIOTIC COMPLEX AND β-GLUCANS | 2024 |
|
RU2834562C1 |
BIOSAUCE PRODUCTION METHOD | 2009 |
|
RU2416342C1 |
PROBIOTIC COMPOSITION FOR RESTORING AND MAINTAINING A BALANCED INTESTINAL MICROFLORA IN CHILDREN AND INFANTS AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2767400C2 |
BIFIDOBACTERIAL AND LACTOBACILLARY CONSORTIUM FOR PREPARING BACTERIAL PREPARATIONS AND DIETARY SUPPLEMENTS FOR CORRECTING GASTROINTESTINAL MICROFLORA IN CHILDREN UNDER AGE OF THREE, AND METHOD FOR PREPARING IT, DIETARY SUPPLEMENT AND BACTERIAL PREPARATION FOR TREATING DYSBIOTIC GASTROINTESTINAL CONDITIONS IN CHILDREN UNDER AGE OF THREE | 2012 |
|
RU2491331C1 |
Authors
Dates
2023-01-24—Published
2022-03-18—Filed